Epidemic keratoconjunctivitis: efficacy of outbreak management.
Martin C, Löw U, Quintin A, Schießl G, Gärtner B, Heim A, Seitz B.
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):173-180. doi: 10.1007/s00417-021-05344-4. Epub 2021 Aug 18.
Epidemic keratoconjunctivitis.
Grist NR, Reid D, Bell EJ, Ellis JR.
Br Med J. 1971 Nov 20;4(5785):488-9. doi: 10.1136/bmj.4.5785.488-e.
Epidemiology of epidemic keratoconjunctivitis.
Ford E, Nelson KE, Warren D.
Epidemiol Rev. 1987;9:244-61. doi: 10.1093/oxfordjournals.epirev.a036304.
Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses.
Gonzalez G, Yawata N, Aoki K, Kitaichi N.
J Clin Virol. 2019 Mar;112:1-9. doi: 10.1016/j.jcv.2019.01.004. Epub 2019 Jan 11.
Epidemic Keratoconjunctivitis: A Growing Concern in Pakistan.
Hijab N, Majid F, Nusrat K.
J Pak Med Assoc. 2024 Aug;74(8):1588. doi: 10.47391/JPMA.10984.
Epidemic Keratoconjunctivitis: (Superficial Punctate Keratitis, Keratitis Subepithelialis, Keratitis Maculosa, Keratitis Nummularis) With a Review of the Literature and a Report of 125 Cases.
Hogan MJ, Crawford JW.
Am J Ophthalmol. 2018 Jun;190:xxix-xlii. doi: 10.1016/j.ajo.2018.03.041.
[Epidemic keratoconjunctivitis].
Janićijević-Petrović MA, Srećković S, Petrović N, Sarenac T.
Srp Arh Celok Lek. 2011 May-Jun;139(5-6):282-5. doi: 10.2298/sarh1106282j.
COVID-19 Pandemic Impact on Epidemic Keratoconjunctivitis.
Khavandi S, Tabibzadeh E, Khavandi S.
Cornea. 2021 Jul 1;40(7):e14-e15. doi: 10.1097/ICO.0000000000002750.
Epidemic keratoconjunctivitis.
Murrah WF.
Ann Ophthalmol. 1988 Jan;20(1):36-8.
Mystery eye: Human adenovirus and the enigma of epidemic keratoconjunctivitis.
Jonas RA, Ung L, Rajaiya J, Chodosh J.
Prog Retin Eye Res. 2020 May;76:100826. doi: 10.1016/j.preteyeres.2019.100826. Epub 2019 Dec 28.
